Uridine Triacetate Patent Expiration
Uridine Triacetate was first introduced by Btg International Inc
Uridine Triacetate Patents
Given below is the list of patents protecting Uridine Triacetate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Vistogard | US5968914 | Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
Oct 19, 2016
(Expired) | Btg Intl |
| Vistogard | US6258795 | Acylated uridine and cytidine and uses thereof |
Jul 10, 2023
(Expired) | Btg Intl |
| Vistogard | US7776838 | Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides | Aug 17, 2027 | Btg Intl |
| Xuriden | US6258795 | Acylated uridine and cytidine and uses thereof |
Jul 10, 2023
(Expired) | Btg Intl |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳